Marvel Biosciences Corp. MRVL.V

Company Overview

Marvel Biosciences Corp. is a Canada-based biotechnology company focused on the research and development of novel, plant-derived therapeutics targeting neurological and neurodegenerative disorders. The company operates within the biotechnology and pharmaceutical research industries, with an emphasis on developing proprietary compounds intended to address conditions with significant unmet medical need. Marvel Biosciences is publicly traded in the United States on the OTC Markets under the ticker MBCOF and in Canada on the Canadian Securities Exchange.

The company’s core strategy centers on the discovery and preclinical development of non-psychoactive, phytochemical-based drug candidates, particularly for diseases such as Parkinson’s and other movement disorders. Marvel Biosciences traces its origins to the late 2010s, when it was formed to commercialize a portfolio of plant-based intellectual property and reposition it toward regulated pharmaceutical pathways rather than consumer wellness products. Since inception, the company has remained in the early-stage development phase, with no commercialized products as of the most recent public disclosures.